Biofrontera (BFRI) Other Non-Current Assets (2020 - 2026)
Biofrontera (BFRI) posted quarterly Other Non-Current Assets of $360000.0 for Q4 2025, down 6.01% year-over-year from $383000.0 in Q4 2024, and down 23.73% quarter-over-quarter from $472000.0 in Q3 2025.
Biofrontera (BFRI) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Biofrontera's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $360000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 6.01% year-over-year to $360000.0; the TTM figure through Dec 2025 stood at $360000.0 (down 6.01% YoY), while the FY2025 annual figure was $360000.0, down 6.01% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $360000.0, down from $472000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.4 million in Q3 2021, with the low at $85000.0 in Q3 2022.
- The 5-year median for Other Non-Current Assets is $383000.0 (2024), against an average of $400176.5.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets slumped 93.81% in 2022, then jumped 478.82% in 2023.
- Biofrontera's Other Non-Current Assets stood at $268000.0 in 2021, then tumbled by 68.28% to $85000.0 in 2022, then surged by 467.06% to $482000.0 in 2023, then declined by 20.54% to $383000.0 in 2024, then declined by 6.01% to $360000.0 in 2025.
- Business Quant data shows BFRI's Other Non-Current Assets at $360000.0 in Q4 2025, $472000.0 in Q3 2025, and $535000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn | 451,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 451,000.00 |
| Dec 31, 2025 | 360,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 535,000.00 |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 383,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Mar 31, 2024 | 328,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | 492,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 85,000.00 |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 128,000.00 |
| Mar 31, 2022 | 268,000.00 |
| Dec 31, 2021 | 268,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Dec 31, 2020 | 121,000.00 |